Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06446388
What this trial is testing

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd. 360
Testing effectiveness (Phase 2)Study completedNCT00900627
What this trial is testing

Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)

Who this might be right for
NeoplasmsBreast NeoplasmsBreast Cancer
AstraZeneca 330
Early research (Phase 1)Study completedNCT01337505
What this trial is testing

Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
ImmunityBio, Inc. 24
Very early researchLooking for participantsNCT06097962
What this trial is testing

Safety and Efficacy of NK510 to Treat NSCLC

Who this might be right for
NSCLC
Base Therapeutics (Shanghai) Co., Ltd. 12
Early research (Phase 1)Active Not RecruitingNCT06059001
What this trial is testing

Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

Who this might be right for
Metastatic Pancreatic Cancer
Peptomyc S.L. 26
Testing effectiveness (Phase 2)Looking for participantsNCT05417594
What this trial is testing

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 695
Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Early research (Phase 1)Study completedNCT05848466
What this trial is testing

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Who this might be right for
Advanced or Metastatic Solid Tumors
Bio-Thera Solutions 23
Not applicableStudy completedNCT01963351
What this trial is testing

Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC

Who this might be right for
Non-small Cell Lung CancerUnresectable Malignant Neoplasm
University of Athens 150
Testing effectiveness (Phase 2)Study completedNCT01847001
What this trial is testing

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Malignant NeoplasmBreast Cancer
Columbia University 10
Early research (Phase 1)Looking for participantsNCT06933069
What this trial is testing

Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors

Who this might be right for
Solid Malignancies
Taizhou Mabtech Pharmaceutical Co.,Ltd 55
Not applicableNot Yet RecruitingNCT04871477
What this trial is testing

Adoption of Audio Recording in the Outpatient Supportive Care Center

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid Neoplasm+2 more
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT04171219
What this trial is testing

Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Early research (Phase 1)Looking for participantsNCT07567222
What this trial is testing

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

Who this might be right for
Malignant Tumor
West China Hospital 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07080619
What this trial is testing

SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers

Who this might be right for
TNBC - Triple-Negative Breast CancerHR+ Breast Cancer
Tianjin ConjuStar Biologics Co., Ltd. 120
Early research (Phase 1)Study completedNCT00678769
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Malignant Neoplasm
National Cancer Institute (NCI) 72
Early research (Phase 1)Study completedNCT01432951
What this trial is testing

Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma, Malignant
Eli Lilly and Company 26
Early research (Phase 1)Study completedNCT02106845
What this trial is testing

Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.

Who this might be right for
Neoplasms
Bayer 42
Testing effectiveness (Phase 2)Study completedNCT02122185
What this trial is testing

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Brenner TumorMalignant AscitesMalignant Pleural Effusion+25 more
University of Chicago 111
Next Page